Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    8562146 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed A Phase I Trial of ZD1694 (TOMUDEX), an Inhibitor of Thymidylate Synthase, in Pediatric Patients With Advanced Neoplastic Disease
Condition: Neoplasm
Intervention: Drug: ZD1694 (TOMUDEX)

Indicates status has not been verified in more than two years